Bio-Rad to Present at Barclays Global Healthcare Conference 2018 on March 14
March 05 2018 - 9:05PM
Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader
of life science research and clinical diagnostic products, today
announced that Norman Schwartz, President and CEO, and Christine
Tsingos, Executive Vice President and CFO, will present at the
Barclays Global Healthcare Conference 2018 on Wednesday, March 14,
at 3:50 PM (EST), at Loews Miami Beach Hotel, Florida.
A link to the live webcast of the presentation is available in
the Investor Relations area of our website atwww.bio-rad.com.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global
leader in developing, manufacturing, and marketing a broad range of
innovative products and solutions for the life science research and
clinical diagnostic markets. With a focus on quality and customer
service for over 65 years, our products advance the discovery
process and improve healthcare. Our customers are university and
research institutions, hospitals, public health and commercial
laboratories, biotechnology, pharmaceutical, as well as applied
research laboratories that include food safety and environmental
quality testing. Founded in 1952, Bio-Rad is based in Hercules,
California, and has a global network of operations with more than
8,000 employees worldwide. Bio-Rad had revenues exceeding $2.1
billion in 2017. For more information, please visit
www.bio-rad.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180305006309/en/
Bio-Rad Laboratories, Inc.Tina Cuccia, 510-724-7000Corporate
Communicationstina_cuccia@bio-rad.com
Bio Rad Laboratories (NYSE:BIO)
Historical Stock Chart
From Apr 2024 to May 2024
Bio Rad Laboratories (NYSE:BIO)
Historical Stock Chart
From May 2023 to May 2024